Skip to main content

Ultomiris 300 mg/3 mL (100 mg/mL) injection Images

Generic Name: ravulizumab

This medication has been identified as Ultomiris 300 mg/3 mL (100 mg/mL) injection. It is supplied by Alexion Pharmaceuticals Inc.

Ultomiris is used in the treatment of Myasthenia Gravis; Paroxysmal Nocturnal Hemoglobinuria; Hemolytic Uremic Syndrome and belongs to the drug class selective immunosuppressants. Ultomiris 300 mg/3 mL (100 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Ultomiris 300 mg/3 mL (100 mg/mL) injection medicine

Ultomiris

Generic Name
ravulizumab
Strength
300 mg/3 mL (100 mg/mL) injection
Availability
Prescription only
Drug Class
Selective immunosuppressants
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alexion Pharmaceuticals Inc.
National Drug Code (NDC)
25682-0025

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.